Clinical trial NCT00689013: The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting
Official title: The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Herpes Zoster
Keywords: Herpes Zoster
Prevention & control
Pharmacists
Pharmacy
Pharmacies
Aged
Immunization
Vaccination
Lead sponsor: University of Tennessee
Sponsor class: OTHER
Collaborators: name: Merck Sharp & Dohme LLC
name: American Pharmacists Association
First posted: 2008-06-03
Enrollment: 205
Sex: ALL
Minimum age (years): 60
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: FACTORIAL
Primary purpose: PREVENTION

Brief summary: The purpose of this study is to determine whether pharmacist-driven patient interventions can have an effect on the number of herpes zoster (Zostavax) vaccinations given in a community pharmacy setting.

Detailed description: Several studies exist documenting the perception and satisfaction of patients receiving immunizations from pharmacists, as well as the effects of pharmacist involvement in advocating and administering vaccinations. The most well documented studies have been conducted in hospital settings. Undoubtedly, there is enormous opportunity for the community pharmacist to identify potential vaccine recipients, advocate immunization and administer said immunizations to their established patient populations. However, there is a lack of concentrated study in the implementation of immunization services in the community setting and their effects. The investigators intend to evaluate the intervention of pharmacists in an immunization program and the resulting changes in immunization rates.

Eligibility criteria: Inclusion Criteria:

* men and women aged 60 or older without contraindications for the herpes zoster vaccination
* patients who have already experienced one or more episodes of herpes zoster infection were considered for vaccine receipt and study inclusion secondary to CDC ACIP recommendations

Exclusion Criteria:

* Patients aged \< 60 years
* Anyone who has previously received the herpes zoster vaccine
* Anyone with an allergy to neomycin, gelatin or any other component of the vaccine
* Anyone receiving a live vaccine within 4 weeks
* Anyone with a compromised or weakened immune systems such as those receiving radiation, corticosteroids, or those with HIV/AIDS, cancer in the lymph, bone or blood systems
* Pregnant women or those in close contact with a pregnant woman

Primary outcomes:
measure: To assess the effect of a pharmacist-driven immunization campaign on the rate of Zostavax immunizations in three separate community pharmacy settings
timeFrame: 2 months
Secondary outcomes:
measure: To evaluate the relative efficacy of specific interventions on the rate of herpes zoster vaccinations
timeFrame: 2 months
measure: To evaluate the perception of patients receiving the herpes zoster vaccination as to the role of pharmacists as immunizers
timeFrame: 2 months
Other outcomes:
Locations:
city: Johnson City
country: United States
facility: Wilson Pharmacy
state: Tennessee
city: Manchester
country: United States
facility: Marcrom's Pharmacy
state: Tennessee
city: Murfreesboro
country: United States
facility: Reeves-Sain Drug Store
state: Tennessee
Study officials:
affiliation: University of Tennessee Community Pharmacy Residency Program
name: Lindsay J Ford, Pharm.D.
role: PRINCIPAL_INVESTIGATOR
affiliation: University of Tennessee Community Pharmacy Residency Program
name: Sarah K Frank, Pharm.D.
role: STUDY_CHAIR
affiliation: University of Tennessee Community Pharmacy Residency Program
name: Nina H Jaber, Pharm.D.
role: STUDY_CHAIR
affiliation: University of Tennessee Community Pharmacy Residency Program
name: Stephan L Foster, Pharm.D.
role: STUDY_DIRECTOR
affiliation: University of Tennessee Community Pharmacy Residency Program
name: Richard Randolph, Pharm.D.
role: STUDY_CHAIR
affiliation: University of Tennessee Community Pharmacy Residency Program
name: Steve Lane, Pharm.D.
role: STUDY_CHAIR
affiliation: University of Tennessee Community Pharmacy Residency Program
name: Cindy T Smith, Pharm.D.
role: STUDY_CHAIR
References: